Promega Switzerland

📢 Job alert! 🔔 We are looking for a Sales and Application Specialist to join our Promega team in Switzerland. The successful candidate will be responsible for building, maintaining and expanding customer relationships in Swiss Romandie by sharing scientific knowledge and promoting our innovative products. If you are a life science graduate enjoying new challenges and eager to support researchers in selecting the best tools for their projects, then this opportunity is for you! Please note that good knowledge of both French and English languages is required for this position. For more information and to apply ➡️ https://bit.ly/3yOav3T

Join us next Wednesday, September 4th, 2024, for our webinar 'Defining CAR T Cell Potency: Advances in Functional Analysis'. 💉💊 Experts from Promega and Axion BioSystems will discuss how the Axion Maestro Z impedence platform and Promega's Lumit® Cytokine Immunoassays, HiBiT Target Cell Killing platform and T cell activation assays can ensure the development of potent and effective CAR T cell therapies. Learn about: ✔️ Understanding cutting-edge tools for functional analysis of CAR T cells ✔️ How integrated approaches combining impedance readouts with Lumit® Immunoassays can enhance the accuracy and reliability of potency measurements ✔️ How you can implement these techniques in your own CAR T research to improve therapeutic efficacy and safety Register now ➡️ https://bit.ly/473t4Og #CellTherapy #CARTcell #Lumit #LumitImmunoassays #HiBiT #Webinar #Axion #PromegaTechnologies

Struggling with the limitations of MTT assays? Our latest article details the challenges of MTT assays and why ATP assays are the most reliable and widely used alternative. Plus, learn more about using the MyGlo™ Reagent Reader with CellTiter-Glo® luminescent assays as a streamlined, cost-effective solution for ATP-based #cellviability assays. Read the article here ➡️ https://bit.ly/4dx6LTG

Immunotherapy has proved to be an efficient strategy against a variety of cancer diseases in humans. The same approach can be applied towards the development of therapies for animal health, including livestock and pets.  We have a whole set of new Bioassays for Biologics targeting animal health such as the canine PD-1/PD-L1 assay, feline PD-1/PD-L1 assay and more; we are also open to build your own assays through our Tailored R&D Solutions Team. Contact us directly for more information! https://lnkd.in/eF-f_CJr

Meet us in Bern next week! 👋 Our team is excited to welcome you to the Promega booth at the Joint Annual Meeting 2024 of the Swiss Society for Infectious (SSI) Diseases, the Swiss for Microbiology (SSM) and the Swiss Society for Hospital Hygiene (SSHH) on August 28th-30th, 2024. Visit us to experience our Maxwell® CSC instrument in action and learn more about our IVDR-compliant nucleic acid purification solutions. We look forward to seeing you there! Learn more and register on the event website ➡️ https://lnkd.in/dm2AA3ch

Fast. Accurate. Reliable. Maxwell® helps you relax. Automating your nucleic acid extractions with Maxwell® benchtop instruments can bring ease into your workflows. It ensures that you: ✅ Consistently extract high-quality DNA/RNA from any sample type ✅ Obtain purified nucleic acids ready for NGS and qPCR workflows ✅ Save at least 40 minutes hands-on time per run with load-and-go methods ✅ Process 1–16 or 1–48 samples at once ✅ Minimize user error with cartridge-based purification kits and intuitive software Until 30 November 2024 save 20% on your Maxwell®️ instrument purchase and start to relax. Offer valid in Switzerland only. Terms and conditions apply. Learn more ➡️ https://bit.ly/4fRlBWw #Maxwell #NucleicAcidExtraction #Automation #PromegaTechnologies

Meet our speakers at the Discover Glo hybrid conference on 8 October 2024. 🗣️ From fundamental oncology research to drug discovery and translational research, our experts will cover exciting topics and present their latest innovations. Follow their presentations live in Paris, or from the comfort of your lab or office if you cannot be there in person! Make sure to book your ticket soon! ➡️ https://bit.ly/3X3pwIu Registration is free of charge. 📆 8 October 2024 ⏲️ 9.00 a.m. to 5.00 p.m. BST 💻 Hybrid format (online or in-person in Paris) #discoverglo #discoverglo24 #bioluminescence

Attending Ilmac 2024? We are excited to welcome you to Lausanne on September 18-19! Visit us at the Promega booth for a relaxing and insightful experience. We have a lot to share with you this year. With the Promega voucher code, you and your colleagues can get your Ilmac tickets for free. All you need to do is register with our code: promega-24. Register here ➡️ https://bit.ly/3yx5TPJ See you there! 🏖️ 📍 Ilmac 2024 | 18-19 September 2024 | Beaulieu Lausanne #Ilmac2024 #Biotechnology #LifeSciences #PromegaTechnologies

Harness the effectiveness of Maxwell® instruments to advance your gene and cell therapy research. From mRNA expression analysis to transgene copy number assays, these tools are crucial for understanding gene expression across various samples and pivotal in the development of effective therapies. Maxwell® instruments stand as indispensable partners through every phase from R&D to clinical trials, handling diverse sample types with unmatched versatility. Step into the future of gene and cell therapy with Maxwell®. Discover more about how these instruments can transform your scientific discoveries. 👉 Explore our technologies: https://bit.ly/4e0t3gv #NucleicAcidExtraction #mRNA #transgene #Maxwell #PromegaTechnologies

Meet our speakers at the Discover Glo hybrid conference on October 8, 2024. 🗣️ From fundamental oncology research to drug discovery and translational research, our experts will cover exciting topics and present their latest innovations. Follow their presentations live or from the comfort of your lab or office. Make sure to book your ticket soon! Registration is free of charge. ➡️ https://lnkd.in/dyQ5f2_G 📆 8 October 2024 ⏲️ 9am to 5pm CEST 💻 Hybrid format (online or in Paris) #discoverglo #discoverglo24 #bioluminescence #oncology #innovation #research #treatments #promegatechnologies #conference